Risk factors of immune-related adverse events in patients with early-stage breast cancer: Findings from a multi-institutional retrospective study

By afschroeder • October 1, 2026

LeVee A, Jacob S, Fisch S, Face C, Chengappa M, Chaudhry S, Baclig N, Soliman A, Ruel N, Wong M, Tsai K, Kang I, Kordic A, Huppert L, Quintal L, Melisko M, Majure M, Chien J, Lechner M, Idossa D, Blaes A, McCann K, Rugo HS, Mortimer J. Risk factors of immune-related adverse events in patients with early-stage breast cancer: Findings from a multi-institutional retrospective study. Breast. 2026 Sep 29;90:104941. doi: 10.1016/j.breast.2026.104941. Epub ahead of print. PMID: 42815081.

Tags: Biomarker, Blood cell counts, breast cancer, Endocrinology, Hematology/Oncology, immune checkpoint inhibitors, immune-related adverse events, Publications

Exposure to per-and polyfluoroalkyl substances and early-onset cancers

van Gerwen M, Monaghan M, Boni A, Florentino Puello M, Petrick LM, Leung AM. Exposure to per-and polyfluoroalkyl substances and early-onset cancers. Carcinogenesis. 2026 Jul[...]

Ceramide synthesis mediates colorectal cancer metastasis through a YAP-driven regenerative program

Goswami S, Zhang Q, Yildiz AB, Das Adhikari U, Raghawan AK, Bulliard M, Sedhain S, Darawshi O, Celik CE, Cansiz F, Krempe CP, Rösler J,[...]

Cardiovascular-kidney-metabolic syndrome as a mitochondrial systems disorder

Li S, Abel ED, Arany Z, Baur JA, Pei L, Susztak K. Cardiovascular-kidney-metabolic syndrome as a mitochondrial systems disorder. Nat Rev Nephrol. 2026 Sep 24.[...]